Table 1.
Demographic characteristics.
| Extraperitoneal Group | Historical Control Group | |||
|---|---|---|---|---|
| n=34 | n=28 | |||
| age (range) | 55 (37-78) | 56 (34-75) | ||
| BMI (range) | 22.6 (19.1-30.3) | 22.3 (18.3-25.7) | ||
| n | % | n | % | |
| FIGO Stage | ||||
| I A | 20 | 58.8 | 17 | 60.7 |
| I B | 7 | 20.5 | 6 | 21.4 |
| III A | 2 | 5.9 | 1 | 3.6 |
| III C1 | 3 | 8.9 | 3 | 10.7 |
| III C2 | 2 | 5.9 | 1 | 3.6 |
| I A with LVSI * | ||||
| negative | 14 | 58.9 | 10 | 64.3 |
| positive | 6 | 41.1 | 7 | 35.7 |
| Histology ** | ||||
| EM G1 | 19 | 55.9 | 15 | 53.6 |
| EM G2 | 8 | 23.5 | 6 | 21.4 |
| EM G3 | 4*** | 11.8 | 4 | 14.3 |
| serous | 2 | 5.9 | 2 | 7.1 |
| others | 1**** | 2.9 | 1***** | 3.6 |
| Chemotherapy | ||||
| yes | 20 | 58.8 | 18 | 64.2 |
| no | 14 | 41.2 | 10 | 35.8 |
| Radiotherapy | ||||
| yes | 0 | 0 | ||
| no | 34 | 100 | 28 | 100 |
*LVI : lymphovascular space invasion; ** EM : endometrioid adenocarcinoma; **** small cell carcinoma; ***** clear cell adenocarcinoma